Abstract:Aim: Breviscapine isolated from the Chinese herb Erigeron breviscapus (Vant) Hand-Mazz is widely used to treat cardiovascular and cerebrovascular diseases. The aim of this study was to improve the pharmacokinetic profiles of breviscapine using nanostructured lipid carrier based on an ionic complex formation. Methods: Breviscapine nanostructured lipid carrier (Bre-NLC) was prepared using the thin film homogenization method. The morphology of Bre-NLCs was determined using transmission electron microscopy. The mean particle size, polydispersity index, zeta-potential analysis and entrapment efficiency were analized. In vitro release was studied using the dialysis method. In vitro stability was studied in fresh plasma and liver slurry of rats. In vivo pharmacokinetics was analyzed in rats after intravenous injection of a dose equivalent to breviscapine (10 mg/kg). Results: The Bre-NLCs were spherical with a mean particle size of ∼170 nm, a zeta potential of ∼20 mV and a high entrapment efficiency of ∼89%. Compared with a commercially available solution, a substantial decrease in the cumulative release of breviscapine was found for the Bre-NLCs. The NLC has a significantly protective effect against the liver enzyme degradation of breviscapine. After intravenous administration in rats, the Bre-NLCs exhibited a 32 times increase in the AUC 0–t and a 12 times increase in T 1/2 as compared to the commercially available breviscapine solution. Conclusion: The results demonstrate that the NLC has great potential to use as a novel sustained release system for breviscapine.

Study on Preparation of Breviscapine Liposomes and Chemicophysical Properties

Preparation, characterization, and biodistribution of breviscapine proliposomes in heart.

Optimized preparation, characterization and biodistribution in heart of breviscapine lipid emulsion.

Study on the liposome/water partition coefficient for breviscapine and its application

Characterization, biodistribution and targeting evaluation of breviscapine lipid emulsions following intravenous injection in mice.

Preparation, characterization and evaluation of breviscapine lipid emulsions coated with monooleate-PEG-COOH.

Lipid emulsion as a drug delivery system for breviscapine: Formulation development and optimization

Development of Ionic-Complex-based Nanostructured Lipid Carriers to Improve the Pharmacokinetic Profiles of Breviscapine

Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes

Application of Uniform Design for Preparation of Breviscapine Liposomes

Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder

Preparation of Breviscapine Oral Disintegrating Tablets

Multivesicular Liposome Formulation for the Sustained Delivery of Breviscapine.

Mechanism of Breviscapine Entrapped by Polymethacrylate Nanospheres

Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method

Preparation of Baicalein-Phospholipid Complex and Its Physic-Chemical Properties

Studies on Preparation Techniques of Ivermectin Liposomes

Preparation and Quality Evaluation of Ivermectin Liposome

Study on Encapsulation Efficiency and in Vitro Release of Baicalin Liposomes

Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.

A study of the cardioprotective effect of breviscapine during hypoxia of cardiomyocytes.